| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007382192 |
| P356 | DOI | 10.1038/KI.1993.259 |
| P698 | PubMed publication ID | 8377384 |
| P5875 | ResearchGate publication ID | 14822690 |
| P2093 | author name string | Cohen AH | |
| Colvin RB | |||
| Solez K | |||
| Croker BP | |||
| Dunnill MS | |||
| Halloran PF | |||
| Droz D | |||
| Burdick JF | |||
| Benediktsson H | |||
| Axelsen RA | |||
| P2860 | cites work | Transplant glomerulopathy: evolution of morphologically distinct changes | Q69901036 |
| Renal allograft cell infiltrates associated with irreversible rejection | Q69920356 | ||
| Pre-discharge, post-transplant kidney biopsy does not predict rejection | Q70226811 | ||
| The value of needle renal allograft biopsy. II: Reflection of acute rejection changes throughout the kidney by percutaneous biopsy | Q70365735 | ||
| Characteristics of early routine renal allograft biopsies | Q70399273 | ||
| Increased expression of HLA-DR antigens on renal tubular cells in renal transplants: relevance to the rejection response | Q72584726 | ||
| Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients | Q34062049 | ||
| Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants | Q36340245 | ||
| The pathology of heart and heart and lung transplantation--an update | Q37551172 | ||
| Primary acute renal failure ("acute tubular necrosis") in the transplanted kidney: morphology and pathogenesis | Q38627203 | ||
| Cyclosporin and renal graft histology | Q39558964 | ||
| Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts | Q39558998 | ||
| Percutaneous needle biopsies of renal allografts: the relationship between morphological changes present in biopsies and subsequent allograft function | Q40921722 | ||
| Glomerulopathy Associated with Cytomegalovirus Viremia in Renal Allografts | Q43927416 | ||
| The strong correlation of cytotoxic T lymphocyte-specific serine protease gene transcripts with renal allograft rejection | Q67735526 | ||
| Tubular ultrastructure in rejected human renal allografts | Q68135883 | ||
| Kidney transplants in cyclosporine-treated Sprague-Dawley rats | Q68704049 | ||
| The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection | Q68704052 | ||
| Sequential analysis of HLA-class II antigen expression in human renal allografts. Induction of tubular class II antigens and correlation with clinical parameters | Q68892404 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| P304 | page(s) | 411-422 | |
| P577 | publication date | 1993-08-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology | |
| P478 | volume | 44 |
| Q26852055 | Q26852055 |
| Q57175415 | A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology |
| Q52724272 | A Humanized Mouse Model Generated Using Surplus Neonatal Tissue. |
| Q87268775 | A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients |
| Q74184432 | A comparison of daclizumab to ATGAM induction in simultaneous pancreas-kidney transplant recipients on triple maintenance immunosuppression |
| Q58747430 | A comparison of the effectiveness of cyclophosphamide, leflunomide, corticosteroids, or conservative management alone in patients with IgA nephropathy: a retrospective observational study |
| Q73277811 | A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints Conference |
| Q53867109 | A multicenter, open-label, comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis. |
| Q43975358 | A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas tran |
| Q33785758 | A neural network approach to the biopsy diagnosis of early acute renal transplant rejection |
| Q52083406 | A neural network approach to the diagnosis of early acute allograft rejection. |
| Q84223935 | A polymorphism of NADPH oxidase p22 phox is associated with reduced susceptibility to acute rejection in renal allograft recipients |
| Q28365781 | A prospective comparison of simultaneous kidney-pancreas transplantation with systemic-enteric versus portal-enteric drainage |
| Q32139934 | A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients |
| Q38211716 | A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection |
| Q41956968 | Acp. Best practice no 160. Renal biopsy specimens |
| Q77176616 | Acute allograft rejection following conversion to a new cyclosporine formulation in pediatric renal transplant patients |
| Q54204663 | Acute rejection and the flow cytometry crossmatch. |
| Q73794924 | Acute rejection in protocol renal transplant biopsies-institutional variations |
| Q73303976 | Acute rejection in renal transplant patients using cyclosporine versus microemulsion-form cyclosporine: incidence and severity |
| Q41398474 | Acute rejection of renal allografts: mechanistic insights and therapeutic options |
| Q77758364 | Acute renal allograft rejection in the canine: evaluation with serial duplex Doppler ultrasonography |
| Q38022714 | Acute vascular rejection after renal transplantation and isolated v-lesion |
| Q41469771 | Adhesion molecules and rejection of renal allografts |
| Q44152814 | Adoptive transfer of HBV immunity by kidney transplantation and the effect of postoperative vaccination |
| Q77856776 | Advances in kidney transplantation: renal failure in the United States |
| Q34178614 | Allografts surviving for 26 to 29 years following living-related kidney transplantation: analysis by light microscopy, in situ hybridization for the Y chromosome, and anti-HLA antibodies |
| Q53667379 | Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury. |
| Q73143730 | An evaluation of the Banff 97 classification after kidney transplantation |
| Q73869561 | An experimental model of chronic kidney allograft rejection under triple-drug treatment in the rat |
| Q73631153 | An immunocytochemical study of H+ ATPase in kidney transplant rejection |
| Q34006687 | Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation |
| Q44237287 | Analysis of allograft biopsy specimens from long-term surviving patients with stable renal function: predictive value of long-term graft prognosis |
| Q41700336 | Anti-inflammatory effects of alphav integrin antagonism in acute kidney allograft rejection |
| Q73693815 | Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells |
| Q73544546 | Antibodies to vascular endothelial cells in chronic rejection of renal allografts |
| Q38392458 | Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management |
| Q77900333 | Apoptosis and expression of cytotoxic T lymphocyte effector molecules in renal allografts |
| Q45958515 | Association between Toll-like receptors 4 and 2 gene polymorphisms with chronic allograft nephropathy in Turkish children. |
| Q73068451 | Attempts to demonstrate indirect T cell allorecognition of donor MHC peptides in transplant patients |
| Q53408830 | Augmentation of Transient Donor Cell Chimerism and Alloantigen-Specific Regulation of Lung Transplants in Miniature Swine. |
| Q38510972 | Banff 2013 update: Pearls and pitfalls in transplant renal pathology |
| Q95307569 | Banff 2019 Meeting Report: Molecular diagnostics in solid organ transplantation - Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation |
| Q38893693 | Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand? |
| Q49680610 | Banff Classification of Polyomavirus Nephropathy: A New Tool for Research and Clinical Practice |
| Q53141154 | Banff fibrosis study: multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies. |
| Q56967420 | Banff survey on antibody-mediated rejection clinical practices in kidney transplantation: Diagnostic misinterpretation has potential therapeutic implications |
| Q33585369 | Basiliximab |
| Q43552814 | Basiliximab significantly reduces acute rejection in renal transplant patients given triple therapy with azathioprine |
| Q44256933 | Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors |
| Q35603779 | Basiliximab: a review of its use as induction therapy in renal transplantation |
| Q33364817 | Benefit-risk assessment of sirolimus in renal transplantation |
| Q30477027 | Biopsy of the transplanted kidney |
| Q73027449 | Borderline changes in kidney transplantation: evolution of treated cases versus nontreated |
| Q53026998 | C4d deposits in borderline rejection: an early marker for chronic renal dysfunction? |
| Q73279537 | CMV increases inflammation and accelerates chronic rejection in rat kidney allografts |
| Q43993070 | Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy |
| Q73027445 | Calcitriol induces apoptosis of incubated lymphocyte T cells from patients with acute renal graft rejection |
| Q39957158 | Can protocol biopsy better inform our choices in renal transplantation? |
| Q73316111 | Carvedilol treatment of kidney graft recipients with chronic rejection |
| Q41141020 | Chronic allograft arteriosclerosis: contributing factors and molecular mechanisms in the light of experimental studies |
| Q36445529 | Chronic allograft injury by subclinical borderline change: evidence from serial protocol biopsies in kidney transplantation |
| Q61877210 | Chronic allograft nephropathy |
| Q36582300 | Chronic allograft nephropathy in paediatric renal transplantation |
| Q34236920 | Chronic allograft nephropathy score before sirolimus rescue predicts allograft function in renal transplant patients |
| Q43759235 | Chronic calcineurin inhibitor nephrotoxicity-lest we forget |
| Q40945138 | Chronic rejection and late renal allograft dysfunction |
| Q84238174 | Chronic rejection of human kidney allografts |
| Q41642401 | Chronic remodeling pathology in grafts |
| Q71754587 | Chronic renal allograft rejection can be predicted by area under the serum creatinine versus time curve (AUCCr) |
| Q40464538 | Chronic renal transplant loss |
| Q72516453 | Chronic renal transplant rejection |
| Q40636661 | Chronic transplant rejection |
| Q61945789 | Circulating adhesion molecules during kidney allograft reperfusion |
| Q47202064 | Clinical and Pathological Analyses of Cases of Acute Vascular Rejection After Kidney Transplantation |
| Q38076666 | Clinical and histological predictors of long-term kidney graft survival. |
| Q42537610 | Clinical and histopathologic examination of renal allografts treated with tacrolimus (FK506) for at least one year |
| Q53149092 | Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation. |
| Q40864183 | Clinical application of immunosuppressive agents in renal transplantation |
| Q73544653 | Clinical correlation of acute rejection according to Banff classification in renal transplantation |
| Q35937515 | Clinical significance of anti-endothelial cell antibody in renal transplant recipients |
| Q73619590 | Clinical significance of selective decline of donor-reactive IL-2-producing T lymphocytes after renal transplantation |
| Q77369817 | Clinical validation of the Banff 97 classification for the diagnosis of rejection in kidney transplant |
| Q50969140 | Clinicopathologic analysis of acute vascular rejection cases after renal transplantation. |
| Q35750109 | Clonal CD8+ T Cell Persistence and Variable Gene Usage Bias in a Human Transplanted Hand |
| Q73279240 | Collagens in chronic rejection of rat renal allografts |
| Q36062030 | Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens |
| Q87441668 | Comparative analysis of inflammatory infiltrates in collagen-induced arthritis, kidney graft rejection and delayed-type hypersensitivity in non-human primates |
| Q35142594 | Complement C4d in graft capillaries -- the missing link in the recognition of humoral alloreactivity |
| Q77177538 | Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys |
| Q44148803 | Contribution of renal scintigraphy to management of patients with acute renal allograft dysfunction. |
| Q77632067 | Correlation between Banff classification acute rejection scores and reversal of rejection |
| Q40549258 | Correlation between ICAM1 and VCAM1 gene polymorphisms and histopathological changes in kidney allograft biopsies |
| Q46777806 | Costs savings associated with thymoglobulin for treatment of acute renal transplant rejection in patient subsets |
| Q33619389 | Critical role of aquaporins in interleukin 1β (IL-1β)-induced inflammation |
| Q38795065 | Current pathological perspectives on chronic rejection in renal allografts |
| Q38843499 | Current status of pediatric renal transplant pathology |
| Q40827565 | Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion |
| Q33652709 | Current understanding of chemokine involvement in allograft transplantation. |
| Q43620712 | Cyclosporine A metabolite AM19 as a potential biomarker in urine for CSA nephropathy |
| Q44511304 | Cyclosporine lymphocyte versus whole blood pharmacokinetic monitoring: correlation with histological findings |
| Q33340247 | De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine a sirolimus combination |
| Q47839666 | Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury |
| Q83446846 | Delayed renal graft function: risk factors and impact on the outcome of transplantation |
| Q40271119 | Detection of Donor-Derived Microparticles in the Peripheral Blood of a Hand Transplant Recipient During Rejection |
| Q47615693 | Development of CD3 cell quantitation algorithms for renal allograft biopsy rejection assessment utilizing open source image analysis software. |
| Q39587972 | Diagnosis of early acute renal allograft rejection by evaluation of multiple histological features using a Bayesian belief network |
| Q90268718 | Diagnosis of renal transplant rejection: Banff classification and beyond |
| Q73027438 | Differences between acute and chronic renal graft rejection on immunohistochemical staining of transforming growth factor beta-1 |
| Q42166917 | Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker |
| Q43551295 | Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients |
| Q40972160 | Dilemmas in renal transplantation: when the clinical course and histological findings differ |
| Q47129289 | Direct immunofluorescence and immunohistochemistry in diagnostics of glomerulonephritis |
| Q43888775 | Do intraoperative hemodynamic factors of the recipient influence renal graft function? |
| Q74616990 | Does cold ischemia induce chronic kidney transplant dysfunction? |
| Q46321479 | Does copy number variation of APOL1 gene affect the susceptibility to focal segmental glomerulosclerosis? |
| Q33806988 | Does subclinical rejection contribute to chronic rejection in renal transplant patients? |
| Q33561691 | Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts |
| Q71913865 | Donor kidney vasculopathy: impact on outcome in kidney transplantation |
| Q46512903 | Down-regulation of TGF-beta and VCAM-1 is associated with successful treatment of chronic rejection in rats |
| Q89049431 | Dual antibody induction and de novo use of everolimus enable low-dose tacrolimus with early corticosteroid withdrawal in simultaneous pancreas-kidney transplantation |
| Q53055638 | Early Macrophage Infiltration and Sustained Inflammation in Kidneys From Deceased Donors Are Associated With Long-Term Renal Function. |
| Q77175936 | Early histopathologic changes predicting long-term kidney transplant survival |
| Q71974528 | Early protocol renal allograft biopsies and graft outcome |
| Q74186102 | Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection |
| Q34460068 | Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens |
| Q37167609 | Effect of losartan on Doppler sonography indices in kidney transplant patients: a randomized clinical trial. |
| Q46751820 | Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group |
| Q54124454 | Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection. |
| Q44067969 | Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation: a single center report |
| Q42161314 | Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. |
| Q43913169 | Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study |
| Q40325148 | Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-year observational results. |
| Q44101463 | Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up |
| Q57943257 | Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study |
| Q73278473 | Electron-microscopic peritubular capillary lesion is a specific and useful diagnostic indicator for chronic rejection of renal allografts showing less specific morphologic lesions in the cyclosporine era |
| Q45882045 | Electroporation-mediated HGF gene transfection protected the kidney against graft injury |
| Q73277778 | Elevated factor VIII as a marker for vascular type of rejection after renal transplantation |
| Q46933489 | Endothelin-1 and endothelin receptor status in kidney transplants undergoing acute rejection |
| Q71126184 | Enhanced glomerular retrieval for renal biopsies |
| Q40663383 | Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy |
| Q73445477 | Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system |
| Q50894529 | Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low Framingham risk scores. |
| Q77425353 | Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction |
| Q43963045 | Experience with basiliximab in pediatric renal transplantation |
| Q73027524 | Experimental study of the cellular energy charge in pig kidney transplants from non-heart-beating donors |
| Q41671711 | Exploring associations between anthropometric indices and graft function in patients receiving renal transplant |
| Q91587601 | Exposure to Hyperchloremia Is Associated with Poor Early Recovery of Kidney Graft Function after Living-Donor Kidney Transplantation: A Propensity Score-Matching Analysis |
| Q77631846 | Expression of Fas/Fas ligand and apoptosis induction during renal allograft rejection |
| Q71834078 | Expression of TGF-beta 1 and matrix proteins is elevated in rats with chronic rejection |
| Q72193024 | Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection |
| Q34788131 | Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats |
| Q44419225 | FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts |
| Q34996895 | Fibrogenesis in chronic allograft rejection: underlying mechanisms and pharmacological control |
| Q40794386 | Focal segmental glomerulosclerosis in renal allografts with chronic nephropathy: implications for graft survival |
| Q52117962 | From first principles--tubulitis in protocol biopsies and learning from history. |
| Q73729622 | Functional magnetic resonance imaging of human renal allografts during the post-transplant period: preliminary observations |
| Q82064936 | Getting to Grips With Glomerulitis |
| Q97887403 | Global Glomerulosclerosis in Kidney Biopsies With Differing Amounts of Cortex: A Clinical-Pathologic Correlation Study |
| Q43963147 | Glomerular hyperfiltration, intrarenal hemodynamics, and chronic allograft nephropathy: physiopathology of chronic allograft nephropathy |
| Q35749813 | Glomerular permselectivity in proteinuric patients after kidney transplantation |
| Q87711218 | Glucocorticoid resistance in dialysis patients reduces long-term graft survival after kidney transplantation |
| Q43114194 | Graft loss among renal-transplant recipients with early reduction of immunosuppression for BK viremia |
| Q43828553 | HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival |
| Q36819204 | Having one kidney does not accelerate the rate of development of diabetic nephropathy lesions in type 1 diabetic patients |
| Q45731872 | Hepatitis C virus infection and de novo glomerular lesions in renal allografts |
| Q74616023 | High risk kidney transplant rejection treatment: cost savings from thymoglobulin |
| Q37349333 | High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients |
| Q38148703 | Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification |
| Q54051408 | Histologic evaluation, HLA-DR expression, and macrophage density of renal biopsies in OKT3-treated acute rejection: comparison with steroid response in acute rejection. |
| Q77758335 | Histologic grading of acute renal allograft rejection |
| Q37964270 | Histology and proteinuria after renal transplantation |
| Q44888245 | Histopathologic findings and classification of feline renal transplants |
| Q73028029 | Histopathologic findings in routine biopsies of renal transplant allografts |
| Q40611715 | Histopathology of a human allografted kidney with clinically sufficient function |
| Q71614030 | Histopathology of renal posttransplant lymphoproliferation: comparison with rejection using the Banff schema |
| Q41169099 | Hyperfiltration nephropathy as a cause of late graft loss in renal transplantation |
| Q61945652 | IL-2 and TNF-α Promoter Polymorphisms in Patients With Acute Kidney Graft Rejection |
| Q35072635 | Identification of common blood gene signatures for the diagnosis of renal and cardiac acute allograft rejection |
| Q33959646 | Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods |
| Q73421733 | IgA nephropathy databank: development of a system for management of renal biopsy acquired data |
| Q49893519 | Immune reconstitution with two different rabbit polyclonal anti-thymocytes globulins |
| Q44173461 | Immunobiology and long-term graft function in a transplant heterotopic renal rat model |
| Q58862574 | Immunohistochemical quantification of leukocyte subsets in the long-term prognosis of kidney transplants |
| Q73303752 | Immunologic monitoring: implications for treatment of rejection |
| Q64993329 | Impact of Remote Ischemic Preconditioning Conducted in Living Kidney Donors on Renal Function in Donors and Recipients Following Living Donor Kidney Transplantation: A Randomized Clinical Trial. |
| Q43552969 | Impact of sirolimus on renal transplant outcomes in African Americans |
| Q36849398 | Impact of specimen adequacy on the assessment of renal allograft biopsy specimens. |
| Q51699103 | Impact of the Banff 2013 classification on the diagnosis of suspicious versus conclusive late antibody-mediated rejection in allografts without acute dysfunction. |
| Q40856044 | In situ localization of C3 synthesis in experimental acute renal allograft rejection |
| Q70865858 | In situ lymphoproliferation in renal transplant biopsies |
| Q39637848 | In vitro bromodeoxyuridine labelling of renal biopsy specimens: correlation between labelling indices and tubular damage |
| Q40624961 | Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft function |
| Q30469626 | Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity |
| Q82888019 | Indicators of acute rejection on Tc-99m DTPA renal scintigraphy |
| Q57975233 | Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy |
| Q34181871 | Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. |
| Q42856697 | Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis |
| Q52083405 | Interinstitutional variation in the performance of Baysian Belief Network for the diagnosis of acute renal graft rejection. |
| Q52999932 | Interleukin-8 expression in patients after renal transplantation. |
| Q40456075 | Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies. |
| Q71324547 | Intragraft TGF-beta 1 mRNA: a correlate of interstitial fibrosis and chronic allograft nephropathy |
| Q70847457 | Intragraft expression of IL-10 messenger RNA: a novel correlate of renal allograft rejection |
| Q73278592 | Intrarenal display of cytotoxic attack molecules during rejection |
| Q73028025 | Is IgA nephropathy in renal transplants a risk leading to graft failure? |
| Q77959248 | Is there any correlation between pathologic changes for acute rejection in kidney transplantation (Banff 97) and graft function? |
| Q50069790 | Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up |
| Q45737663 | Kidney transplantation in patients with chronic hepatitis B virus infection: is the prognosis worse? |
| Q35153318 | Late kidney allograft loss: what we know about it, and what we can do about it |
| Q72633396 | Late-acute renal allograft rejection and symptomless cytomegalovirus infection |
| Q46937106 | Lipid and oxidative stress disorders in a rat model of chronic rejection |
| Q43429258 | Living-related pediatric renal transplants: a single-center experience from a developing country |
| Q71875611 | Local graft irradiation after failure of modern immunosuppression in acute cellular and vascular graft rejection |
| Q43628304 | Long-term (> or =20 yr) status of 14 cadaveric kidney-transplant recipients |
| Q73219760 | Long-term evaluation of two protocols of elective cyclosporine withdrawal in renal transplant recipients |
| Q44471183 | Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression |
| Q44342937 | Long-term impact of pneumoperitoneum used for laparoscopic donor nephrectomy on renal function and histomorphology in donor and recipient rats |
| Q47939678 | Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation |
| Q43955490 | Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation - results from an aborted trial |
| Q47202072 | Lorraine Racusen and Kim Solez Awarded the Gold Medal of the Catalan Transplant Society |
| Q43720153 | Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. |
| Q53325028 | Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantation. |
| Q73604873 | Lupus nephritis |
| Q80033012 | MRI investigations of graft rejection following organ transplantation using rodent models |
| Q44471188 | Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts. |
| Q49916971 | Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection |
| Q44237283 | Mast cells in human allografted kidney: correlation with interstitial fibrosis |
| Q38633087 | Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN |
| Q41734033 | Mechanisms and management of acute renal allograft rejection |
| Q26740172 | Mechanisms and risk assessment of steroid resistance in acute kidney transplant rejection |
| Q64252507 | Metabolomics Approaches for the Diagnosis and Understanding of Kidney Diseases |
| Q49070122 | MicroCRP: a highly sensitive CRP method applied in the monitoring of renal allograft recipients |
| Q84456236 | Microarray gene expression profiling of chronic allograft nephropathy in the rat kidney transplant model |
| Q73336373 | Microchimerism and rejection in clinical transplantation |
| Q33711255 | Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. |
| Q73490438 | Monitoring of anti-HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantation |
| Q33832354 | Morphology and immunohistochemistry of rat aortic grafts |
| Q34457313 | Morphometric and visual evaluation of fibrosis in renal biopsies |
| Q37397724 | Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: cohort study |
| Q78691580 | Mucosal vascular alterations in isolated small-bowel allografts: relationship to humoral sensitization |
| Q73277931 | Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation |
| Q53049415 | Multifocal renal allograft biopsy: impact on therapeutic decisions. |
| Q53639918 | Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients. |
| Q43640097 | Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients |
| Q73314783 | Mycophenolate mofetil-based immunosuppressive therapy: induction, maintenance, and conversion protocols in renal transplantation |
| Q58024471 | Nephrosclerosis and carotid atherosclerosis: Lessons from kidney donor histology |
| Q37112788 | New Magnetic Resonance Imaging Index for Renal Fibrosis Assessment: A Comparison between Diffusion-Weighted Imaging and T1 Mapping with Histological Validation |
| Q37272222 | Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts |
| Q71964284 | Nonimmunologic causes of late renal graft loss |
| Q77176653 | Nonmuscle and smooth muscle myosin heavy-chain expression in rat renal allografts |
| Q46400608 | Oral supplement of six selective amino acids arrest progression renal failure in uremic patients |
| Q90414221 | Organ preservation solution containing dissolved hydrogen gas from a hydrogen-absorbing alloy canister improves function of transplanted ischemic kidneys in miniature pigs |
| Q45221738 | Paradoxical cyclosporine A requirements in pediatric renal transplants receiving high-dose steroids |
| Q85675894 | Pathological spectrums and renal prognosis of severe lupus patients with rapidly progressive glomerulonephritis |
| Q83700004 | Pathology: donor biopsy evaluation at time of renal grafting |
| Q54262749 | Patient survival after renal transplantation: II. The impact of smoking. |
| Q39345384 | Pediatric renal transplant biopsy with ultrasound guidance: the 'core' essentials |
| Q78007082 | Percutaneous renal biopsy: three years of experience with the biopty gun in 761 cases--a survey of results and complications |
| Q53033816 | Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. |
| Q33337472 | Phase III trial of Rapamune versus placebo in primary renal allograft recipients |
| Q38005448 | Phenotypes of antibody-mediated rejection in organ transplants |
| Q73277791 | Plasmapheresis for the treatment of acute vascular rejection in renal transplantation |
| Q73648044 | Platelet-specific alloantigens in cadaveric renal transplantation. A prospective study. Effect of HPA-5b mismatch in acute vascular rejection of renal allografts |
| Q38668319 | Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients |
| Q49724104 | Polyomavirus BK Nephropathy-Associated Transcriptomic Signatures: A Critical Reevaluation |
| Q46752108 | Power Doppler imaging and resistance index measurement in the evaluation of acute renal transplant rejection. |
| Q80375980 | Practice guidelines for the renal biopsy |
| Q40736051 | Pre-transplant end-stage renal disease-related immune risk profile in kidney transplant recipients predicts post-transplant infections. |
| Q47940207 | Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation |
| Q46965979 | Predictive value of Banff score of early kidney allograft biopsies for 1-year graft survival. |
| Q56975282 | Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts |
| Q36906015 | Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. |
| Q73353458 | Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys |
| Q41485015 | Primary care of patients with renal transplants |
| Q36577199 | Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts |
| Q36635047 | Primer: histopathology of polyomavirus-associated nephropathy in renal allografts |
| Q52598766 | Proceedings of the 2nd BEAT-PCD conference and 3rd PCD training school: part 1. |
| Q50198363 | Quantification of Interstitial Fibrosis in Renal Allografts and Clinical Correlates of Long-Term Graft Function |
| Q33774364 | Quantitation of allograft fibrosis and chronic allograft nephropathy. |
| Q73740573 | Quantitation of change in the medullary compartment in renal allograft by ultrasound |
| Q77177370 | Quantitative competitive polymerase chain reaction: design and synthesis of mRNA-specific competitor DNA templates and their clinical usage |
| Q35961030 | Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation |
| Q46740685 | Racial differences in renal allograft survival: the role of systemic hypertension. |
| Q72155531 | Radionuclide evaluation of renal transplants |
| Q57377991 | Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression |
| Q47887130 | Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group |
| Q73794901 | Randomized trial comparing neoral and tacrolimus immunousuppression for recipients of renal transplants procured from different donor groups |
| Q45057936 | Real Time Central Assessment of Kidney Transplant Indication Biopsies by Microarrays: The INTERCOMEX Study. |
| Q74416112 | Reduction in acute rejections decreases chronic rejection graft failure in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) |
| Q77177454 | Rejection after kidney transplantation: new concepts, new therapeutic options |
| Q34823896 | Rejection and recipient age. |
| Q49628113 | Rejection evaluation after renal transplantation using MR diffusion tensor imaging. |
| Q35796217 | Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study |
| Q47831129 | Relationship between diurnal blood pressure and renal histopathological changes in white coat hypertension. |
| Q73868588 | Relationship between macrophage infiltration of renal allografts and chronic renal impairment |
| Q77632078 | Relationship of renal implantation biopsies and acute rejection during the immediate posttransplantation period |
| Q44228024 | Relationships between arterial hypertension and renal allograft survival in African-American patients. |
| Q52845695 | Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient. |
| Q26799509 | Renal Biopsy in Type 2 Diabetic Patients |
| Q37611251 | Renal Transplant Patients Biopsied for Cause and Tested for C4d, DSA, and IgG Subclasses and C1q: Which Humoral Markers Improve Diagnosis and Outcomes? |
| Q44601147 | Renal Transplantation in a Case of Acute Intermittent Porphyria |
| Q73544613 | Renal allograft outcome from cytomegalovirus seronegative donor into cytomegalovirus seronegative recipient: poor prognosis after seroconversion |
| Q71704429 | Renal allograft rejection in children and young adults: the Banff classification |
| Q40879682 | Renal biopsy collagen I mRNA predicts scarring in rabbit anti-GBM disease: comparison with conventional measures |
| Q81407644 | Renal transplant biopsy specimen adequacy in a paediatric population |
| Q72753037 | Renal transplantation |
| Q58868704 | Renin–angiotensin system blockade and kidney transplantation: a longitudinal cohort study |
| Q33632174 | Report of the Radionuclides in Nephrourology Committee for evaluation of transplanted kidney (review of techniques). |
| Q74348093 | Results of a small series of renal graft biopsies in a Lebanese population |
| Q36349405 | Risk Stratification for Rejection and Infection after Kidney Transplantation |
| Q35140692 | Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxis |
| Q73598689 | Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft |
| Q36937329 | SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. |
| Q74613772 | Screening for basiliximab exposure-response relationships in renal allotransplantation |
| Q44412726 | Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: relationship with proteinuria and therapeutic response to enalapril. |
| Q79804707 | Semiquantitative and semi-automated morphometric evaluation of chronic lesions in renal biopsies |
| Q74571196 | Sensitivity of radionuclide imaging, Doppler, and gray-scale ultrasound to detect acute rejection episodes, based on the pathologic grade of acute rejection |
| Q44077279 | Severe antibody-mediated rejection following IVIG infusion in a kidney transplant recipient with BK-virus nephropathy |
| Q23923238 | Sex differences in response to cyclosporine immunosuppression in experimental kidney transplantation |
| Q100395204 | Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis |
| Q77758328 | Significance of chronic transplant nephropathy on early protocol biopsies for graft outcome in pediatric renal transplantation |
| Q44029432 | Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis |
| Q73902028 | Significance of serum creatinine pattern and area under the creatinine versus time curve during the first acute renal transplant rejection |
| Q41139286 | Significance of the Banff borderline biopsy |
| Q44419230 | Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates1 |
| Q41681683 | Single-centre study of 628 adult, primary kidney transplant recipients showing no unfavourable effect of new-onset diabetes after transplant |
| Q43552838 | Sirolimus is effective for prevention of acute rejection in primary mismatched renal allograft recipients |
| Q42654342 | Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients |
| Q36200170 | Sirolimus: the evidence for clinical pharmacokinetic monitoring. |
| Q36949237 | Statin use is associated with prolonged survival of renal transplant recipients. |
| Q56907639 | Study of lymphocyte costimulatory molecules in renal transplantation |
| Q45353014 | Subclinical Epstein-Barr virus viremia among adult renal transplant recipients: incidence and consequences |
| Q47595221 | T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts. |
| Q60748376 | TNF-α IFN-γ IL-6, IL-10, and TGF-β1 gene polymorphisms in renal allografts |
| Q74414594 | Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation |
| Q74616120 | Tacrolimus in renal transplantation: a comparison of induction vs noninduction therapy (triple therapy): three-month results |
| Q44101169 | Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up |
| Q43504722 | Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach |
| Q74613821 | Tacrolimus vs Neoral in renal and renal/pancreas transplantation |
| Q36054132 | The Application of Digital Pathology to Improve Accuracy in Glomerular Enumeration in Renal Biopsies |
| Q77069139 | The BANFF classification: a pan-European study |
| Q38067050 | The Banff classification revisited |
| Q38676925 | The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations |
| Q33636560 | The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design |
| Q81562856 | The art of classifying renal allograft pathology |
| Q46112070 | The bridge between transplantation and regenerative medicine: Beginning a new Banff classification of tissue engineering pathology |
| Q34784762 | The case against protocol kidney biopsies |
| Q50193450 | The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion |
| Q36682686 | The classification and treatment of antibody-mediated renal allograft injury: where do we stand? |
| Q43828492 | The efficacy and safety of mizoribine in living donor kidney transplantation: a 24-week, open-label, prospective study (phase III clinical trial). |
| Q38885079 | The epidermal growth factor receptor pathway in chronic kidney diseases |
| Q33884782 | The evolution of the Banff classification schema for diagnosing renal allograft rejection and its implications for clinicians |
| Q45342464 | The extent of HLA-DR expression on HLA-DR(+) Tregs allows the identification of patients with clinically relevant borderline rejection |
| Q71769742 | The humoral immune response towards HLA class II determinants in renal transplantation |
| Q43928123 | The impact of ICAM1 and VCAM1 gene polymorphisms on chronic allograft nephropathy and transplanted kidney function |
| Q44188441 | The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients |
| Q34421534 | The impact of late acute rejection after cadaveric kidney transplantation |
| Q39812222 | The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. |
| Q73668798 | The new Banff classification of renal transplant biopsies: a major impact on the adequacy of the cores taken |
| Q37813404 | The pathology of chronic allograft dysfunction |
| Q77743596 | The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation |
| Q42174540 | The relationship between renal volume and histology in obese and nonobese kidney donors. |
| Q41168688 | The renal allograft biopsy |
| Q84909970 | The role of thin-layer cytology in the clinical management of renal transplantation |
| Q48162490 | The time dependency of renal allograft histology |
| Q46841454 | The utility of 1- and 3-month protocol biopsies on renal allograft function: a randomized controlled study |
| Q33332141 | Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity |
| Q70918692 | Thromboxane synthase expression co-localizes with infiltrating macrophages in renal allograft biopsies |
| Q33344619 | Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: a single centre experience |
| Q73522002 | Tissue kallikrein in transplant kidney |
| Q39148338 | Toll-like receptor 4 and CD14 gene polymorphisms in Tunisian kidney transplantation |
| Q53117621 | Total inflammation in early protocol kidney graft biopsies does not predict progression of fibrosis at one year post-transplant. |
| Q90663092 | Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria |
| Q26778752 | Translational research in kidney transplantation and the role of patient engagement |
| Q73027306 | Transplant vasculopathy in early protocol renal allograft biopsies |
| Q74234588 | Treatment of antibody-mediated accelerated rejection using plasmapheresis |
| Q43963143 | Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation: a Spanish multicenter study |
| Q63431639 | Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: single-center experience in 40 patients |
| Q73682864 | Treatment of kidney transplants with chronic rejection using angiotensin-converting enzyme inhibitors |
| Q44437918 | Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to Cyclosporine-based immunosuppressive regimens in renal transplantation |
| Q54262576 | Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies. |
| Q43993060 | Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study |
| Q99584602 | Urinary Protein Biomarker Panel for the Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Recipients |
| Q50743724 | Using Molecular Phenotyping to Guide Improvements in the Histologic Diagnosis of T Cell-Mediated Rejection. |
| Q38721753 | Vascularized composite allotransplantation: a closer look at the banff working classification |
| Q88344636 | Virtual Touch Tissue Quantification for Assessing Renal Pathology in Idiopathic Nephrotic Syndrome |
| Q44419281 | WOFIE synergizes with calcineurin-inhibitor treatment and early steroid withdrawal in kidney transplantation1 |
| Q40622573 | Wedge Versus Core Biopsy at Time Zero: Which Provides Better Predictive Value for Delayed Graft Function With the Remuzzi Histological Scoring System? |
| Q26796641 | What is the best way to measure renal fibrosis?: A pathologist’s perspective |
| Q52899752 | Why rejections are not biopsy proven: frequency and reasons. |
| Q38510775 | Zoom endoscopic monitoring of small bowel allograft rejection |
| Q81581820 | [Indications and long-term outcomes for solid organ transplant. Quality of life in solid organ transplant recipients] |
| Q80110666 | [Isotopic studies in pediatric nephrourology] |
| Q84215841 | [New faces of acute rejection in 2008] |
| Q79979192 | [The discovery of capillary Cd4 in kidney transplantation and the "renaissance" of humoral rejection] |
| Q34302240 | mTOR inhibitors: an overview |
Search more.